BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 11012080)

  • 1. Molecular correlates of the action of bis(ethyl)polyamines in breast cancer cell growth inhibition and apoptosis.
    Faaland CA; Thomas TJ; Balabhadrapathruni S; Langer T; Mian S; Shirahata A; Gallo MA; Thomas T
    Biochem Cell Biol; 2000; 78(4):415-26. PubMed ID: 11012080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major increases in spermidine/spermine-N1-acetyltransferase activity by spermine analogues and their relationship to polyamine depletion and growth inhibition in L1210 cells.
    Libby PR; Henderson M; Bergeron RJ; Porter CW
    Cancer Res; 1989 Nov; 49(22):6226-31. PubMed ID: 2804970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative abilities of bis(ethyl) derivatives of putrescine, spermidine, and spermine to regulate polyamine biosynthesis and inhibit L1210 leukemia cell growth.
    Porter CW; McManis J; Casero RA; Bergeron RJ
    Cancer Res; 1987 Jun; 47(11):2821-5. PubMed ID: 3567905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations between polyamine analogue-induced increases in spermidine/spermine N1-acetyltransferase activity, polyamine pool depletion, and growth inhibition in human melanoma cell lines.
    Porter CW; Ganis B; Libby PR; Bergeron RJ
    Cancer Res; 1991 Jul; 51(14):3715-20. PubMed ID: 2065327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective cellular depletion of mitochondrial DNA by the polyamine analog N1,N12-bis(ethyl)spermine and its relationship to polyamine structure and function.
    Vertino PM; Beerman TA; Kelly EJ; Bergeron RJ; Porter CW
    Mol Pharmacol; 1991 Apr; 39(4):487-94. PubMed ID: 2017149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of N1,N11-bis(ethyl)norspermine against human melanoma xenografts and possible biochemical correlates of drug action.
    Porter CW; Bernacki RJ; Miller J; Bergeron RJ
    Cancer Res; 1993 Feb; 53(3):581-6. PubMed ID: 8425191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the growth of various human and mouse tumor cells by 1,15-bis(ethylamino)-4,8,12-triazapentadecane.
    Igarashi K; Koga K; He Y; Shimogori T; Ekimoto H; Kashiwagi K; Shirahata A
    Cancer Res; 1995 Jun; 55(12):2615-9. PubMed ID: 7780977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of estrogenic and nuclear factor kappa B functions by polyamines and their role in polyamine analog-induced apoptosis of breast cancer cells.
    Shah N; Thomas TJ; Lewis JS; Klinge CM; Shirahata A; Gelinas C; Thomas T
    Oncogene; 2001 Mar; 20(14):1715-29. PubMed ID: 11313919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of ornithine decarboxylase suppression and polyamine depletion in the antiproliferative activity of polyamine analogs.
    Ghoda L; Basu HS; Porter CW; Marton LJ; Coffino P
    Mol Pharmacol; 1992 Aug; 42(2):302-6. PubMed ID: 1513327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of N1,N14-bis(ethyl)homospermine on the growth of U-87 MG and SF-126 human brain tumor cells.
    Basu HS; Pellarin M; Feuerstein BG; Deen DF; Bergeron RJ; Marton LJ
    Cancer Res; 1990 Jun; 50(11):3137-40. PubMed ID: 2334909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological properties of N4- and N1,N8-spermidine derivatives in cultured L1210 leukemia cells.
    Porter CW; Cavanaugh PF; Stolowich N; Ganis B; Kelly E; Bergeron RJ
    Cancer Res; 1985 May; 45(5):2050-7. PubMed ID: 3921235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of N,N'-bis(ethyl)spermine homologues against human MALME-3 melanoma xenografts.
    Bernacki RJ; Bergeron RJ; Porter CW
    Cancer Res; 1992 May; 52(9):2424-30. PubMed ID: 1568212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth inhibition of hormone-responsive and -resistant human breast cancer cells in culture by N1, N12-bis(ethyl)spermine.
    Davidson NE; Mank AR; Prestigiacomo LJ; Bergeron RJ; Casero RA
    Cancer Res; 1993 May; 53(9):2071-5. PubMed ID: 8481909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The growth inhibitory effect of N1,N12-bis(ethyl)spermine in small cell lung cancer cells is maintained in cells expressing the c-myc and Ha-ras oncogenes.
    Barr LF; Campbell SE; Tamez P; Casero RA
    Clin Cancer Res; 1998 Jun; 4(6):1557-61. PubMed ID: 9626477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collateral sensitivity of human melanoma multidrug-resistant variants to the polyamine analogue, N1,N11-diethylnorspermine.
    Porter CW; Ganis B; Rustum Y; Wrzosek C; Kramer DL; Bergeron RJ
    Cancer Res; 1994 Nov; 54(22):5917-24. PubMed ID: 7954423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of programmed cell death in human breast cancer cells by an unsymmetrically alkylated polyamine analogue.
    McCloskey DE; Casero RA; Woster PM; Davidson NE
    Cancer Res; 1995 Aug; 55(15):3233-6. PubMed ID: 7614453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of the spermine analog, N1, N12-bis(ethyl)-spermine, on polyamine metabolism and cell growth in human melanoma cell lines and melanocytes.
    Shappell NW; Miller JT; Bergeron RJ; Porter CW
    Anticancer Res; 1992; 12(4):1083-9. PubMed ID: 1503400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cell growth in CaCO2 cells by the polyamine analogue N1,N12-bis(ethyl)spermine is preceded by a reduction in MYC oncoprotein levels.
    Berchtold CM; Tamez P; Kensler TW; Casero RA
    J Cell Physiol; 1998 Mar; 174(3):380-6. PubMed ID: 9462700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyamine analogue induction of programmed cell death in human lung tumor cells.
    McCloskey DE; Yang J; Woster PM; Davidson NE; Casero RA
    Clin Cancer Res; 1996 Mar; 2(3):441-6. PubMed ID: 9816189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.
    Regenass U; Mett H; Stanek J; Mueller M; Kramer D; Porter CW
    Cancer Res; 1994 Jun; 54(12):3210-7. PubMed ID: 8205541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.